← Back to Search

DCE-MRI and DWI for Breast Cancer (ACRIN6702 Trial)

N/A
Waitlist Available
Led By Savannah Partridge, PhD
Research Sponsored by American College of Radiology Imaging Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

ACRIN6702 Trial Summary

A type of magnetic resonance imaging called diffusion weighted imaging (DWI) will be tested to define cancerous from non-cancerous lesions in the breast.

Eligible Conditions
  • Breast Cancer
  • Breast Imaging Reporting and Data System (BI-RADS)

ACRIN6702 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Apparent Diffusion Coefficient (ADC)
Secondary outcome measures
ADC Measurements/Ratios to Define Subject Lesion Variations
Combination Variables (ADC Nonzero Minimum B-Value and/or Normalized ADC)
Local and Central Review Comparison (ADC Value Differences)
+2 more

ACRIN6702 Trial Design

1Treatment groups
Experimental Treatment
Group I: DCE-MRI and DWIExperimental Treatment1 Intervention
Single arm study, diagnosis defined as BIRADS 3, 4, or 5 lesion(s) based on DCE-MRI only with DWI collected in tandem as standard practice.

Find a Location

Who is running the clinical trial?

American College of Radiology Imaging NetworkLead Sponsor
39 Previous Clinical Trials
465,860 Total Patients Enrolled
7 Trials studying Breast Cancer
51,357 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,734 Previous Clinical Trials
40,967,504 Total Patients Enrolled
943 Trials studying Breast Cancer
1,543,908 Patients Enrolled for Breast Cancer
Eastern Cooperative Oncology GroupNETWORK
268 Previous Clinical Trials
151,495 Total Patients Enrolled
30 Trials studying Breast Cancer
45,987 Patients Enrolled for Breast Cancer
~9 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top